Health
The Indian Express

Manushi Chhillar’s morning ritual includes methylene blue; expert says, ‘not a health supplement’

Source Entity

The Indian Express

October 6, 2026
Manushi Chhillar’s morning ritual includes methylene blue; expert says, ‘not a health supplement’

Actor Manushi Chhillar recently shared her use of methylene blue as a morning supplement, sparking debate. Medical experts emphasize that this substance is a prescription medication, not a health supplement, and carries significant risks if used improperly.

The Intersection of Celebrity Influence and Medical Safety

In a recent social media disclosure, actor and model Manushi Chhillar highlighted a unconventional addition to her morning wellness routine: methylene blue. Attributing her enhanced energy and cognitive focus to this substance, the revelation has ignited a necessary conversation regarding the intersection of celebrity health trends and rigorous medical reality. While Chhillar explicitly noted that her usage is "prescribed and supervised by my physician," the public promotion of such substances often risks being misinterpreted by followers seeking shortcuts to performance optimization.

Understanding Methylene Blue: Beyond the Hype

To provide clarity, it is essential to distinguish between the chemical properties of methylene blue and the current trend of biohacking. As noted by Dr. Pooja Pillai of Aster CMI Hospital, methylene blue is fundamentally a prescription medicine. Its primary, clinically validated use is the treatment of methemoglobinemia, a rare and serious blood disorder where the blood’s ability to carry oxygen is severely impaired. It is not, by any medical definition, a dietary supplement or a standard health tonic intended for the general public.

The Risks of Off-Label Usage

The trend of using prescription-grade chemicals for cognitive enhancement—often termed 'nootropic' use—carries substantial risks. When substances like methylene blue are used outside of strictly controlled, supervised clinical settings, they can interact dangerously with other medications, particularly antidepressants and certain herbal supplements. The lack of standardized dosing for 'wellness' applications means that individuals experimenting without medical oversight are susceptible to toxic side effects that are often ignored in social media testimonials.

The Responsibility of Public Platforms

Celebrity endorsements, even those framed as personal wellness tips, exert significant influence on health behaviors. When a public figure shares a routine involving potent pharmaceuticals, the nuance of "physician supervision" is frequently lost on the audience. This creates a dangerous precedent where complex medical interventions are trivialized as simple lifestyle hacks. It is critical for the public to recognize that what works for an individual under strict medical monitoring may be hazardous to the average person.

Navigating Modern Wellness Trends

In an era where social media platforms have become primary sources for health information, the burden of verification remains heavy. The narrative surrounding Manushi Chhillar’s routine serves as a case study for the necessity of critical thinking. Consumers must move beyond the aesthetic appeal of a 'morning ritual' and demand scientific evidence. The consensus among medical professionals remains clear: prescription medications should never be adopted based on social media trends, regardless of the perceived benefits.

Concluding Thoughts on Health Literacy

Ultimately, the discourse surrounding methylene blue underscores a broader need for improved health literacy. While the pursuit of peak performance is a common goal, it should not supersede the foundational principles of safety and evidence-based medicine. As the disclaimer in this instance rightly suggests, any departure from standard health practices must involve a direct consultation with a licensed medical practitioner to ensure that potential risks are mitigated by professional oversight.

Verification Required?

Read the full report from the primary source

Go to The Indian Express